...henicol palmitate ? Crystalline forms (晶型)? Polymorphs( 多晶型)?Amorphous( 无定型) ?Solvates ( 溶剂化物) Solvates (溶剂化物)Some drugs interact with solvent to form a crystal called solvate (药物结晶时与溶媒形成的分子复合物)..
2
?溶合物
... 溶合电子 solvated electron 溶合物solvates 溶合能 solvation energy ...
Disclosed are the ERK inhibitors of Formula (1.0) : and the pharmaceutically acceptable salts and solvates thereof.
所公开的是式(1.0)的ERK抑制剂；及其药学上可接受的盐和溶剂合物。
2
This invention relates to novel prostacyclin derivatives, their acceptable acid addition salts, solvates, hydrates and polymorphs thereof.
本发明涉及新型的前列环素衍生物及其可接受的酸加成盐、溶剂化 物、水合物及多晶型物。
3
The present invention also provides pharmaceutical compositions comprising compounds of formula (4), their pharmaceutically acceptable salts and solvates.